References
Original article
Li, X. et al. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. Br. J. Cancer https://doi.org/10.1038/s41416-023-02359-y (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masone, M.C. Nicardipine inhibits chemoresistance in prostate cancer. Nat Rev Urol 20, 519 (2023). https://doi.org/10.1038/s41585-023-00810-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-023-00810-6
- Springer Nature Limited